000 01040 a2200301 4500
005 20250515144938.0
264 0 _c20081118
008 200811s 0 0 eng d
022 _a1592-8721
024 7 _a10.3324/haematol.13750
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTarghetta, C
245 0 0 _aRisk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma.
_h[electronic resource]
260 _bHaematologica
_cNov 2008
300 _ae66 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aHepatitis B
_xdrug therapy
650 0 4 _aHepatitis C
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aLymphoma, Non-Hodgkin
_xdrug therapy
650 0 4 _aRisk Factors
700 1 _aCabras, M G
700 1 _aAngelucci, E
773 0 _tHaematologica
_gvol. 93
_gno. 11
_gp. e66
856 4 0 _uhttps://doi.org/10.3324/haematol.13750
_zAvailable from publisher's website
999 _c18439931
_d18439931